The difference of muscular relaxant metabolism under anethesia in pediatric patients

The difference of muscular relaxant metabolism under anethesia in pediatric patients - Mucle relaxant in pediatric patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019692

Enrollment

100

Registered

2015-11-09

Start date

2015-11-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric patients aged 0-15y who will recieve the operation under general anesthesia

Interventions

Muscular relaxant

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pediatric patients who will receive the operation under general anesthesia.

Exclusion criteria

Exclusion criteria: renal function degeneracy

Design outcomes

Primary

Measure	Time frame
The concentrations of musclar relaxtant (at the three points)	—

Countries

Japan

Contacts

Public ContactYukako Abukawa

Tokyo Women's Medical University Department of anesthesia

yukakoabukawasandy@yahoo.co.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026